Loading
Loading
Source Filing
Executive Record
Reported Pay
Compensation pending.
Findings
Reviewing FY2025 executive compensation against shareholder return and the latest filing-backed pay disclosures.
Spread between reported pay and stock performance is pending computation.
Evidence is sourced from the latest executive compensation filing and return series for SYK.
Team view
6 executives
Officer and President
Total PayFY2025
$21.4M
Orthopaedics
Total PayFY2025
$6.3M
Group President,
Total PayFY2025
$6.3M
Total PayFY2025
$4.4M
Group President,
Total PayFY2025
$4.2M
Chief Financial Officer
Total PayFY2025
$1.9M
Ask a question about this filing
01FY2025 total compensation breakdown
Activity timeline · FY2025
Recent events from filings
Mar 23, 2026
Annual Bonus Equity award
A pay-performance summary will appear here once the verdict loads above.
02Pay changes vs. stock performance
1 year of data
Peer context
Dashed line marks the large-cap median compensation benchmark for companies around $130.6B market cap, based on 312 peers in this size band.
03Recent insider trades by officers and directors
~32 trades
04Showing FY2025 data (latest available)
FY2026 does not include director compensation in our current dataset, so we're showing the latest board table we found.
We're loading the latest director compensation and board makeup.
05Take action on executive compensation
Shareholder activism tools
Start or join campaigns to engage with SYK's board on executive compensation, governance, and shareholder proposals.
Activism Beta — Sign in to start or join campaigns
06For analysts and deep research
Historical compensation data from latest proxy filing
| Year | Executive | Salary | Bonus & Incentive | Stock Awards | Option Awards | Other Adj. | Total |
|---|---|---|---|---|---|---|---|
| 2025 | Kevin A. Lobo Officer and President | $1.49M | $2.25M | $9.76M | $6.92M | $0.97M | $21.4M |
| 2025 | Spencer S. Stiles Orthopaedics | $0.79M | $0.76M | $2.69M | $1.90M | $0.19M | $6.33M |
| 2025 | J. Andrew Pierce Group President, | $0.79M | $0.75M | $2.69M | $1.90M | $0.19M | $6.32M |
| 2025 | Preston W. Wells | $0.65M | $0.51M | $1.84M | $1.30M | $0.10M | $4.41M |
| 2025 | Viju S. Menon Group President, | $0.68M | $0.58M | $1.65M | $1.17M | $0.17M | $4.24M |
| 2025 | Glenn S. Boehnlein Chief Financial Officer | $0.80M | $0.80M | $0.00M | $0.00M | $0.29M | $1.89M |
| 2024 | Kevin A. Lobo Officer and President | $1.44M | $2.94M | $8.70M | $8.00M | $0.90M | $22.0M |
| 2024 | Advisor to Officer and Former Vice | $0.79M | $1.08M | $2.72M | $2.51M | $0.24M | $7.34M |
| 2024 | Glenn S. Boehnlein Chief Financial Officer | $0.79M | $1.08M | $2.72M | $2.51M | $0.24M | $7.34M |
| 2024 | Spencer S. Stiles Orthopaedics | $0.75M | $0.92M | $2.54M | $2.34M | $0.21M | $6.76M |
| 2024 | J. Andrew Pierce Group President Med Surg | $0.75M | $0.92M | $2.54M | $2.34M | $0.21M | $6.76M |
| 2024 | Viju S. Menon Quality and Operations | $0.65M | $0.75M | $1.57M | $1.45M | $0.18M | $4.59M |
| 2023 | Kevin A. Lobo Officer and President | $1.39M | $3.78M | $6.65M | $8.41M | $0.53M | $20.8M |
| 2023 | Advisor to Officer and Former Vice | $0.76M | $1.37M | $2.02M | $2.55M | $0.14M | $6.84M |
| 2023 | Glenn S. Boehnlein Chief Financial Officer | $0.76M | $1.37M | $2.02M | $2.55M | $0.14M | $6.84M |
| 2023 | Med Surg and Neurotechnology | $0.72M | $1.17M | $1.97M | $2.49M | $0.13M | $6.49M |
| 2023 | J. Andrew Pierce Group President Med Surg | $0.72M | $1.17M | $1.97M | $2.49M | $0.13M | $6.49M |
| 2023 | Spencer S. Stiles Orthopaedics | $0.72M | $1.17M | $1.97M | $2.49M | $0.13M | $6.49M |
| 2023 | Viju S. Menon Quality and Operations | $0.62M | $0.96M | $1.23M | $1.56M | $0.11M | $4.47M |
| 2022 | Kevin A. Lobo Officer and President | $1.34M | $1.51M | $6.53M | $8.73M | $0.46M | $18.6M |
| 2022 | Glenn S. Boehnlein Chief Financial Officer | $0.73M | $0.55M | $1.89M | $2.53M | $0.15M | $5.85M |
| 2022 | Med Surg and Neurotechnology | $0.70M | $0.48M | $1.89M | $2.53M | $0.14M | $5.74M |
| 2022 | J. Andrew Pierce Group President Med Surg | $0.70M | $0.48M | $1.89M | $2.53M | $0.14M | $5.74M |
| 2022 | Spencer S. Stiles Orthopaedics | $0.70M | $0.45M | $1.89M | $2.53M | $0.14M | $5.71M |
| 2022 | Viju S. Menon Quality and Operations | $0.57M | $0.36M | $1.13M | $1.51M | $0.11M | $3.68M |
| 2021 | Kevin A. Lobo Officer and President | $1.31M | $1.82M | $5.97M | $6.80M | $0.47M | $16.4M |
| 2021 | Glenn S. Boehnlein Chief Financial Officer | $0.71M | $0.62M | $2.63M | $1.93M | $0.13M | $6.02M |
| 2021 | Med Surg and Neurotechnology | $0.67M | $0.62M | $2.33M | $1.53M | $0.12M | $5.26M |
| 2021 | Orthopaedics and Spine | $0.67M | $0.55M | $2.33M | $1.53M | $0.12M | $5.19M |
| 2021 | Viju S. Menon Quality and Operations | $0.55M | $0.44M | $1.98M | $1.19M | $0.10M | $4.26M |
Salary = base cash pay. Bonus & Incentive combines annual bonus and non-equity plans. Equity amounts are grant-date fair values. Other Adj. captures pension changes, perquisites, and any reconciliation items so the total matches the reported figure.
Get one email when new executive compensation data is filed and processed.